Deepmind Alphafold News Today

It won't be long for artificial intelligence can handle drug discovery for pharmaceutical companies without human scientists.

DeepMind CEO Demis Hassabis is both excited and worried about the AI funding frenzy. He acknowledges the potential of AI but warns of the dangers of excessive investment in generative AI startups. Hassabis remains optimistic about AI’s impact and cites DeepMind’s AlphaFold project as evidence.

DeepMind co-founder warns against the gold rush mentality Sir Demis Hassabis, co-founder of DeepMind, has warned that the rush to throw cash at artifi...

PM Modi to address rallies in Rajasthan and Uttarakhand for Lok Sabha elections, focusing on Jaipur Rural and Nainital-Udham Singh Nagar. Amit Shah to meet JD(S) leaders in Karnataka, while Andhra Pradesh CM Jagan Mohan Reddy continues campaign. Lalu Prasad’s daughter to start campaign in Bihar.

This hype, he fears, is clouding the impressive advancements being made in AI

Peter Leimbigler is a Data Science Team Leader within the Consulting practice at Klick Health. We caught up with Peter to learn more about AI work for clients with LLMs.

AlphaGeometry is capable of solving geometry problems at the level of the brightest high-school students.

The Google AI research and development lab DeepMind thinks that finding innovative solutions to difficult geometric problems could be the key to building AI systems with greater capability. In light of this, DeepMind has introduced AlphaGeometry, a system that the research group claims can answer twice as many geometry questions as the typical IMT Olympiad …

Isomorphic Labs, a London-based spin-out of Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google's AI R&D division DeepMind, has announced strategic part

Isomorphic Labs, the drug discovery-focused spinout of Google's DeepMind division, has landed deals with pharma companies worth ~$3 billion.